That is 0 articles you have read today.
The Aporia is free and carries no advertising, so readers are the only
thing paying for it. If you are getting this much out of it, a small
donation is what keeps it independent.
You have read 0 articles today.
That is more than the 15 a day The Aporia gives away,
and well past what it can carry on nothing. Your allowance resets at
midnight.
There is no advertising here and nothing about you is sold, so readers
are the only thing paying for it. If the site is worth this much of
your day, it is worth a few dollars.
Everything else stays open: the front page, the
directory and search do
not count against this, and neither does re-opening something you have
already read today.
Photo via Toronto Star
White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans
Perrone, M. (2026, November 18). White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans. Toronto Star. https://www.thestar.com/news/world/united-states/white-house-pulls-fda-nominee-heidi-overton-after-wavering-support-from-senate-republicans/article_b5b4b993-98a9-598d-8a00-ccb4acd917b5.html
Perrone, Matthew. “White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans.” Toronto Star, 18 Nov. 2026, https://www.thestar.com/news/world/united-states/white-house-pulls-fda-nominee-heidi-overton-after-wavering-support-from-senate-republicans/article_b5b4b993-98a9-598d-8a00-ccb4acd917b5.html.
Perrone, Matthew. “White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans.” Toronto Star, November 18, 2026. https://www.thestar.com/news/world/united-states/white-house-pulls-fda-nominee-heidi-overton-after-wavering-support-from-senate-republicans/article_b5b4b993-98a9-598d-8a00-ccb4acd917b5.html.
Dated from the outlet's own feed. Check the original for its byline.
Toronto Star
· collected 2026-11-18 · by Matthew Perrone
Quick Summary
The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration due to insufficient Senate Republican support. Overton, a Trump-aligned physician and White House domestic policy adviser, was nominated in August to replace Dr. Marty Makary, who had a controversial tenure. Her nomination was intended to stabilize the FDA with a Trump loyalist, but faced opposition that prevented her from gaining the necessary votes for confirmation.
Written by AI on 2026-11-18,
from this article's own text only (the story summary below draws on all the coverage).
11 outlets covered “White House withdraws Heidi Overton’s nomination to become”.
What each outlet says
One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.
Toronto StarThis outlet18 Nov
The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration due to insufficient Senate Republican support. Overton, a Trump-aligned physician and White House domestic policy adviser, was nominated in August to replace Dr. Marty Makary, who had a controversial tenure. Her nomination was intended to stabilize the FDA with a Trump loyalist, but faced opposition that prevented…
White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans (this article)CBS News18 Nov
The White House has withdrawn Dr. Heidi Overton's nomination as the new FDA commissioner, a position she was selected for by President Trump. The Senate health committee was set to vote on her nomination on Wednesday, but the White House has since decided to remove her from consideration. Axios was the first to report this change.
The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) due to insufficient support from Senate lawmakers. Overton, a physician and deputy director of the White House Domestic Policy Council, faced significant opposition for her alleged ties to the tobacco industry, pro-vaping stance, and anti-abortion views. Critics demonstrated their disapproval by placing signs…
The White House has withdrawn Heidi Overton’s nomination to lead the US Food and Drug Administration (FDA) before her confirmation hearing, according to Axios. The decision was made due to a lack of congressional support, especially after criticism from a former Health Secretary’s adviser and opposition from several Republican senators. This move adds to the FDA’s ongoing leadership challenges, with the agency…
The White House has withdrawn Dr. Heidi Overton’s nomination to become the FDA commissioner due to Republican senators' concerns about her lack of managerial experience. The decision came shortly before Overton’s scheduled Senate Health Committee vote, where she needed at least one Republican vote to advance. Senators Cassidy, Collins, and Murkowski expressed reservations about Overton’s qualifications and her…
The White House withdrew Heidi Overton's nomination for a position at the FDA on the day before a Senate committee was set to vote on it, according to a White House official.
Dr. Heidi Overton's nomination to become the FDA commissioner was withdrawn on Tuesday after facing significant opposition from some Republican senators. The nomination encountered hurdles primarily due to Overton’s positions on abortion, vaccines, and vaping, according to sources familiar with the situation.
The White House has withdrawn Heidi Overton's nomination to lead the Food and Drug Administration (FDA) just one day before her scheduled vote by the Senate Health, Education, Labor and Pensions Committee. Overton, a physician and deputy director of the White House Domestic Policy Council, faced skepticism from some Republicans about her involvement in changing childhood vaccine recommendations. A senior…
The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration after bipartisan concerns about her willingness to challenge President Trump’s policies, particularly regarding vaccines and abortion. Republican senator Bill Cassidy, who chairs the Senate health committee, had expressed reservations about her support for Trump’s vaccine plans and her stance on abortion rights…
The White House has withdrawn Heidi Overton’s nomination to become the next FDA commissioner, just before the Senate Health, Education, Labor and Pensions Committee was scheduled to review her nomination on Wednesday. A White House official confirmed the withdrawal to the Washington Examiner on Tuesday.
The Trump administration withdrew Heidi Overton’s nomination to lead the FDA on November 18, 2026, due to lack of support in the Senate. Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated in August and faced opposition from Democrats, some Republicans, and MAHA activists. The White House cited the need for a more populist approach to health as the reason for the…
The effort on peptides, driven by Kennedy’s Department of Health and Human Services, faced overwhelming pushback among FDA drug staffers who warned it could undermine the agency’s longstanding mission of keeping unproven health products off the U.S. market, according to the people familiar with its development.
The Food and Drug Administration says its ongoing safety review of the nation’s main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug’s use curtailed.
At a MAHA summit featuring AI and Silicon Valley executives, Kennedy declared that the technology would free Americans from “medical tyranny” by allowing them to “fact check their own medical advice.”
WASHINGTON (AP) — President Donald Trump’s nominee to take over the Food and Drug Administration is set to answer questions Thursday, with Senate lawmakers likely to focus on her plans for vaccines, the abortion pill and other products that have come under new scrutiny at the regulatory agency.
Your data may be shared with advertisers, social media companies and others
Americans often assume that any personal health information they share is protected by HIPAA, the federal privacy law that governs the handling of medical information.
The White House said Tuesday it has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration amid growing indications she didn’t have the votes needed to win Senate confirmation.
asserted
she → say → confirmation
Overton, a physician and White House domestic policy adviser, has spent most of her professional career working directly for Trump or conservative groups aligned with his agenda.
asserted
Overton → spend → agenda
Her nomination in August was seen as a move to bring a stabilizing Trump loyalist to the FDA after a tumultous year under Trump’s first FDA commissioner, Dr. Marty Makary.
asserted
nomination → see → commissioner
Give feedback · no sign-in needed
No sign-in needed for now. Your note is sent without a name, so it cannot be answered.